The use of cholesterol-lowering medications and age-related macular degeneration

Ophthalmology

Volumn 112, Issue 3, 2005, Pages 488-494

  McGwin Jr , Gerald ^a,b   Xie, Aiyuan ^b   Owsley, Cynthia ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; CLOFIBRATE; COLESTIPOL; COLESTYRAMINE; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; RISK REDUCTION; STATISTICAL SIGNIFICANCE; UNITED STATES;

EID: 14644394842     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2004.10.027     Document Type: Article

References (33)

1. C.H. Hennekens Current perspectives on lipid lowering with statins to decrease risk of cardiovascular disease Clin Cardiol 24 suppl 2001 2 5
2. L.J. Miller, R. Chacko The role of cholesterol and statins in Alzheimer's disease Ann Pharmacother 38 2004 91 98
3. D.C. Bauer, G.R. Mundy, S.A. Jamal Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials Arch Intern Med 164 2004 146 152
4. G. McGwin Jr, C. Owsley, C. Curcio, R.J. Crain The association between statin use and age related maculopathy Br J Ophthalmol 87 2003 1121 1125
5. C.A. McCarty, B.N. Mukesh, R.H. Guymer Cholesterol-lowering medications reduce the risk of age-related maculopathy progression [letter] Med J Aust 175 2001 340
6. N.F. Hall, C.R. Gale, H. Syddall Risk of macular degeneration in users of statins: cross sectional study BMJ 323 2001 375 376
7. R. Klein, B.E. Klein, S.C. Jensen Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study Arch Ophthalmol 119 2001 1354 1359
8. R. Klein, B.E. Klein, S.C. Tomany Relation of statin use to the 5-year incidence and progression of age-related maculopathy Arch Ophthalmol 121 2003 1151 1155
9. R. van Leeuwen, J.R. Vingerling, A. Hofman Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement BMJ 326 2003 255 256
10. R. van Leeuwen, S.C. Tomany, J.J. Wang Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents Ophthalmology 111 2004 1169 1175
11. C.A. McCarty, B.N. Mukesh, C.L. Fu Risk factors for age-related maculopathy: the Visual Impairment Project Arch Ophthalmol 119 2001 1455 1462
12. R. Klein, B.E. Klein Do statins prevent age-related macular degeneration? Am J Ophthalmol 137 2004 747 749
13. G. Malek, C.M. Li, C. Guidry Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy Am J Pathol 162 2003 413 425
14. C.A. Curcio, C.L. Millican, T. Bailey, H.S. Kruth Accumulation of cholesterol with age in human Bruch's membrane Invest Ophthalmol Vis Sci 42 2001 265 274
15. Eye Disease Case-Control Study Group Risk factors for neovascular age-related macular degeneration Arch Ophthalmol 110 1992 1701 1708
16. R. Klein, B.E. Klein, T. Franke The relationship of cardiovascular disease and its risk factors to age-related maculopathy The Beaver Dam Eye Study Ophthalmology 100 1993 406 414
17. C. Delcourt, F. Michel, A. Colvez POLA Study Group Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study Ophthalmic Epidemiol 8 2001 237 249
18. W. Smith, J. Assink, R. Klein Risk factors for age-related macular degeneration: pooled findings from three continents Ophthalmology 108 2001 697 704
19. N. Werner, G. Nickenig, U. Laufs Pleiotropic effects of HMG-CoA reductase inhibitors Basic Res Cardiol 97 2002 105 116
20. ARIC Investigators The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives Am J Epidemiol 129 1989 687 702
21. R. Jackson, L.E. Chambless, K. Yang Atherosclerosis Risk in Communities (ARIC) Study Investigators Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity J Clin Epidemiol 49 1996 1441 1446
22. Hubbard LD, Brothers RJ, King WN, et al, Atherosclerosis Risk in Communities Study Group. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999;106:2269-80.
23. Atherosclerosis Risk in Communities (ARIC) Study Research Group ARIC Retinal Photography Protocol, Manual 14A 1996 NC: ARIC Coordinating Center, Department of Biostatistics (CSCC), University of North Carolina Chapel Hill
24. Atherosclerosis Risk in Communities (ARIC) Study Research Group ARIC Retinal Reading Center Protocol, Manual 14B 1996 NC: ARIC Coordinating Center, Department of Biostatistics (CSCC), University of North Carolina Chapel Hill
25. Klein R, Davis MD, Magli YL, et al. Wisconsin Age-Related Maculopathy Grading System. Springfield, VA: National Technical Information Service; 1991. NTIS Publication PB91-184267.
26. R. Klein, M.D. Davis, Y.L. Magli The Wisconsin Age- Related Maculopathy Grading System Ophthalmology 98 1991 1128 1134
27. G. Maldonado, S. Greenland Simulation study of confounder-selection strategies Am J Epidemiol 138 1993 923 936
28. H.L. Wilson, D.M. Schwartz, H.R. Bhatt Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration Am J Ophthalmol 137 2004 615 624
29. J.M. Seddon, G. Gensler, R.C. Milton Association between C-reactive protein and age-related macular degeneration JAMA 291 2004 704 710
30. T. Takeda, S. Hoshida, M. Nishino Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels Atherosclerosis 169 2003 155 158
31. R. Klein, T. Peto, A. Bird, M.R. Vannewkirk The epidemiology of age-related macular degeneration Am J Ophthalmol 137 2004 486 495
32. S.C. Tomany, J.J. Wang, R. Van Leeuwen Risk factors for incident age-related macular degeneration: pooled findings from 3 continents Ophthalmology 111 2004 1280 1287
33. R. Klein, L. Clegg, L.S. Cooper Atheroslerosis Risk in Communities Study Investigators Prevalence of age-related maculopathy in the Atherosclerosis Risk in Communities Study Arch Ophthalmol 117 1999 1203 1210